Autologous Stem Cell Therapy in Patients With Multiple System Atrophy

Abstract

This study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate functional outcomes, motor performance, and quality of life compared to placebo/controlled group. Phase: PHASE2 Status: NOT_YET_RECRUITING Conditions: MSA - Multiple System Atrophy; MSA Interventions: MSCs; Placebo

Keywords

Sources